Rectal Carcinoma — Trials

Rectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

332 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 52
Ph III recruiting: 6
Growth YoY: +8.7%
Industry share: 2%
Top sponsor: City of Hope Medical Center
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 51–100 of 332 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07669220	A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial)(STAR)	recruiting	Phase 2	76	Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER	1	Jun 25, 2026	clinicaltrials
NCT04929028	Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer	active not recruiting	Phase 2	40	National Cancer Institute (NCI)